Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

BACKGROUND: The use of circulating tumor cells (CTCs) as indicators of treatment response in metastatic colorectal cancer (mCRC) needs to be clarified. The objective of this study is to compare the Response Evaluation Criteria in Solid Tumors (RECIST) with the Cytologic Criteria Assessing Response (...

詳細記述

保存先:
書誌詳細
出版年:J Transl Med
主要な著者: Delgado-Ureña, Mayte, Ortega, Francisco G., de Miguel-Pérez, Diego, Rodriguez-Martínez, Alba, García-Puche, Jose L., Ilyine, Hugh, Lorente, Jose A., Exposito-Hernandez, Jose, Garrido-Navas, M. Carmen, Delgado-Ramirez, Miguel, Serrano, M. José
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6127986/
https://ncbi.nlm.nih.gov/pubmed/30189880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-018-1624-2
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料